ev3

ev3 was a leading global medical device company focused on the endovascular treatment of peripheral vascular and neurovascular diseases. The company's portfolio included innovative technologies such as the Onyx Liquid Embolic System for brain arteriovenous malformations and the Solitaire Revascularization Device, a pioneering stent retriever for acute ischemic stroke. In the peripheral space, ev3 was well-known for its TurboHawk and SilverHawk atherectomy systems used to treat peripheral artery disease. Founded in 2000 and headquartered in Plymouth, Minnesota, the company grew rapidly through strategic acquisitions, including its 2006 merger with Micro Therapeutics. ev3 was acquired by Covidien in 2010 for approximately $2.6 billion and its products now form a core part of Medtronic's restorative therapies and vascular businesses.